Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Biktarvy 50mg/200mg/25mg tablets
0503010AQBBAAAA
|
Biktarvy | Bictegravir/emtricitabine/tenofovir alafenamide | Infections | 10 |
|
Biktarvy 30mg/120mg/15mg tablets
0503010AQBBABAB
|
Biktarvy | Bictegravir/emtricitabine/tenofovir alafenamide | Infections | 1 |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.